Maia Biotechnology, Inc. (NYSE American:MAIA), a biotechnology company with a market capitalization of $52.7 million, announced it has entered into a stock purchase agreement with Prevail Partners ...

Under the terms of the royalty purchase agreement, MacroGenics received a $70 million upfront payment for the sale of its royalty rights on global net sales of ZYNYZ. Following Sagard's receipt of ...

Under the agreements, JERA will secure LNG at competitive pricing, with flexible contract terms and no destination ...

MacroGenics received $70 million upfront cash payment from Sagard Healthcare Partners (Sagard)MacroGenics’ cash runway extended through first half of 2027 ROCKVILLE, MD, June 10, 2025 (GLOBE ...

How to Structure a Buyout of a Partner Company. Although acquaintances or friends co-found partnerships, as time passes, the circumstances that led to the creation of a partnership change. One ...

Initiates Voluntary Chapter 11 Process to Implement Sales  Continuing to Provide Clients with Cutting-Edge Solutions and Unmatched Service During Sale Process CHICAGO, June 24, 2025 /PRNewswire/ -- ...

Inflexion’s initiative to expand portfolio companies to North America via add-on acquisitions is making “very meaningful” ...

Additional information regarding the royalty purchase agreement is provided in a Current Report on Form 8-K filed by MacroGenics with the U.S. Securities and Exchange Commission.

In business as in life, nothing is static. When corporations merge or enter into asset or interest purchase transactions, the ...

The new general partners of Minnesota's basketball teams say they have no intention of moving the teams, but must replace ...

Qatar Sports Investments, the majority-owner of European Champions Paris Saint-Germain, has signed an investment and ...